$SFIX

Bacos Anthony sold $265K of SFIX

Bacos Anthony (Chief Prod/Technology Officer) sold 70,000 shares of Stitch Fix, Inc. (SFIX) at an average of $3.79 ($3.76–$3.80, $0.27M total) across 2 trades on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bacos Anthony
Published Jul 8, 2026, 10:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SFIX
Neutral
high confidence
Mentioned
$SFIX
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SFIXNeutralLow
01

Why it matters

The disclosure updates the record of insider activity, but it does not include new company performance, guidance, or material events.

02

Market read

Primarily a sentiment datapoint for SFIX, with limited fundamental implications due to the 10b5-1 nature of the sale.

03

What to watch

Traders should check whether there are concurrent insider buys or other filings around the same period; this article alone does not establish a trend.

Relevance 3/10Novelty 3/10Timing: after-hours filing on 2026-07-08 for a 2026-07-06 insider sale

Background

This is an SEC Form 4 insider transaction for Stitch Fix, Inc., reported by an officer (Chief Prod/Technology Officer).

Company-level read

Ticker impact

$SFIXNeutralHigh confidence
Context

Insider Form 4 shows Anthony Bacos, Stitch Fix CTO, sold 70,000 shares on 2026-07-06 under a 10b5-1 plan for about $265k.

Expected impact

Likely minimal price impact; any effect is short-lived unless followed by additional disclosures.

Evidence & confidence

The filing is a scheduled open-market sale (10b5-1) with modest dollar value relative to typical market moves, and no new operating or financial guidance is disclosed.

Market effects

No direct sector read-through; this is company-specific insider trading disclosure.

None.

None.

Counterpoint

Because it is explicitly a pre-arranged 10b5-1 plan, the sale may reflect liquidity planning rather than bearish expectations.

Key entities

  • Stitch Fix, Inc.

    Company whose insider transaction was reported on Form 4.

  • Bacos Anthony

    Chief Prod/Technology Officer who sold shares under a 10b5-1 plan.

Related articles

$SFIXMedAI 8/10

Why Stitch Fix Stock Surged Today

Stitch Fix shares rose 15.69% on Thursday after the company reported fiscal 2026 Q3 results that beat investor expectations. Revenue increased 4.7% to $340 million; net revenue per active client rose 6.6% to $578. Net loss narrowed to $1.5 million, free cash flow was $6.5 million, and adjusted EBITDA rose 20% to $13.2 million. Stitch Fix raised full-year guidance to about $1.35 billion revenue and $49–$52 million adjusted EBITDA, with positive free cash flow.

$ORCLMedAI 8/10

Futures Rise, Oil Drops As US Ends Iran Strikes

US equity futures rose as tech and small caps gained after US Central Command said strikes against Iran were complete, easing concerns about further escalation and the Strait of Hormuz reopening. S&P futures rose 0.7% and Nasdaq 100 1.1%; bond yields fell 1–3bp. Brent slipped ~1% below $92; WTI fell to $88.87. Oracle shares fell ~8% after higher-than-estimated capex; Navan jumped 19% after raising revenue outlook.